Results in toxicity cases are dependent on the speed of starting treatment, and the severity of the situation, hence
Storage guidance: Because retatrutide is an investigational product, storage and handling requirements are defined by the trial sponsor, the pharmacy supplying the medication, and the Investigator's Brochure
Products assigned a boxed warning carry risks of severe harm or death
It takes about three weeks to start working, and maintenance is crucial since none of the treatments produce permanent results
Conversely, the gastrointestinal side effects of semaglutide, such as nausea and decreased appetite, could complicate the management of fertility treatment regimens
FDA recently published a Warning Letter (dated June 8, 2012) to Michelle's Miracle, Inc